Journal of Advanced Pharmaceutical Technology & Research

ERRATUM
Year
: 2021  |  Volume : 12  |  Issue : 4  |  Page : 435-

Erratum: In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor


 

Correspondence Address:




How to cite this article:
. Erratum: In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor.J Adv Pharm Technol Res 2021;12:435-435


How to cite this URL:
. Erratum: In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor. J Adv Pharm Technol Res [serial online] 2021 [cited 2022 Jan 21 ];12:435-435
Available from: https://www.japtr.org/text.asp?2021/12/4/435/328640


Full Text



In the article titled “In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor”, published on pages 261-266, Issue 3, Volume 12 of Journal of Advanced Pharmaceutical Technology & Research,[1] the list of authors is incorrectly written as Putu Gita Maya, Widyaswari Mahayasih, Harizal, Herman, Islamudin Ahmad. The correct list of authors and their affiliation should read as below:

Putu Gita Maya Widyaswari Mahayasih1, Harizal1, Herman2, Islamudin Ahmad3

1Department of Pharmacy, Faculty of Health Sciences, Universitas Esa Unggul, West Jakarta, DKI Jakarta, Indonesia

2Laboratory of Pharmaceutical Research and Development of FARMAKA TROPIS, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, Indonesia

3Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia

The “How to cite this article” section should read correctly as “Mahayasih PG, Harizal, Herman, Ahmad I. In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor. J Adv Pharm Technol Res 2021;12:261-6”.

References

1Maya PG, Mahayasih W, Harizal, Herman, Ahmad I. In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor. J Adv Pharm Technol Res 2021;12:261-6.